The Traderszone Network

Published in TZ Latest News 8 November, 2016 by The TZ Newswire Staff

Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October — Here’s Why

Close Pu Microscope Science Clinical Trial
Image source: Getty Images.

Investors in Regeneron Pharmaceuticals (NASDAQ: REGN) had a rough October. Shares of the biotech giant fell 14.3% during the month, according to data from S&P Global Market Intelligence. 

read more